Rivulet Media Inc (fka RIVU)

[PG]

Sabai, you are very much incorrect. MEDS primary focus is ERC's to treat various diseases. ERC's differ very much from other stem cell therapies such as that which is presently being studied & tested (and FDA approved I am certain) by Regen. There are a myriad of differences among the various stem cell treatments. They might be on the same stem cell highway but they are driving completely different vehicles, carrying different cargo.

Further, the MIN science invention applies a novel method for cancer therapy--it is the silencing of immunosuppressive cancer causing genes using short interfering RNA or siRNA leading to an increase in the immune response, a decrease in tumor-induced immunosuppression and a decrease in tumor progression.

Dr. Min mentored Dr. Ichim for years. And to some great extent still very much does. If you will note, Dr. Min brings something altogether different to Regen. The collaboration of these two great minds is what is separates Regen from the rest.

I did speak in detail about the science with Dr. Ichim during my conversation with him on 17 July I believe it was. Regen does not rely on MEDS nor does MEDS rely on Regen.

I am long & strong BMSN, ENTB, & MEDS.